TFRC and chronic kidney disease: The mean values of soluble transferrin receptor (sTfR) in patients with CKD was higher than controls although this was not statistically significant which is similar to report of study done by Toima et al.21 The treatment of CKD patients with ESA would increase the total erythroid mass by increasing sTfR.